ALFA FinderNESCO Shares Rise 5% in 1 Day Since BMC Commencement Certificate for Tower-2 And Hall-1
Nesco Ltd receives the BMC Commencement Certificate for Tower-2 and Hall-1 at Nesco Center, Goregaon. This enables construction for its ₹3,500 crore expansion.
Approvals
Regulatory approvals, licences and clearances.
Grasim Industries Shares Rise 5% in 3 Days Since CCI Nod for ABReN to Buy Solenergi Power
Grasim Industries subsidiary Aditya Birla Renewables receives CCI approval to acquire 100% of Solenergi Power from Shell Overseas Investment. Details here.
Basilic Fly Studio Shareholders Approve Migration to NSE and BSE Main Boards
Basilic Fly Studio shareholders unanimously approve migration from NSE Emerge to the Main Boards of NSE and BSE. Company targets FY27 revenue of up to ₹540 Cr.
Hikal Shares Jump 10% in 2 Days Since Bengaluru API Plant Secured Swissmedic GMP Certification
Hikal Ltd (524735) secures Swissmedic GMP certification for its Bengaluru API facility, enabling expanded supply access to European and regulated global markets!
Sun Pharmaceutical Industries Shares Jump 10% in 6 Days Since Regulatory Approval
Sun Pharmaceutical Industries Ltd receives US FDA approval for ILUMYA in adults with active psoriatic arthritis, expanding its specialty dermatology portfolio.
RNFI Services Receives RBI Approval for Acquisition of Smart Payment Solutions
RNFI Services receives RBI no-objection for the acquisition of Smart Payment Solutions, a licensed PPI issuer, to expand its digital payment capabilities.
Shalby Shares Rise 5% in 6 Days Since Resuming Full Operations at Jabalpur Hospital
Shalby Limited receives CMHO approval to resume full operations at its Jabalpur hospital. The facility is now operational across all floors after renovations.
Karnika Industries Initiates Main Board Migration Process via Postal Ballot
Karnika Industries (NSE: KARNIKA) announces a postal ballot to migrate from NSE Emerge to the NSE and BSE Main Boards, aiming to enhance liquidity and visibility.
Bondada Engineering Secures NSE Main Board Listing Approval for SME Migration
Bondada Engineering receives final approval to migrate from BSE SME to the NSE Main Board. The company holds a ₹10,023 crore order book as of July 2026.
Mukka Proteins Secures US FDA Registration for Facility Through December 2027
Mukka Proteins receives US FDA facility registration valid until Dec 2027. The approval supports US market expansion as company eyes ₹3,000 Cr revenue by FY30.
Canara Bank Receives RBI Approval for ₹1,500 Crore AT1 Bond Call Option
Canara Bank receives RBI permission to exercise a call option on ₹1,500 crore Basel III AT1 bonds. The redemption is slated for December 2026.
Alembic Pharma Receives USFDA Approval for Valganciclovir Oral Solution
Alembic Pharmaceuticals receives USFDA final approval for Valganciclovir for Oral Solution, marking its 247th ANDA approval and strengthening its US portfolio.
KFin Technologies Secures Foreign Business License for Thailand Subsidiary Expansion
KFin Technologies’ Thai subsidiary receives a Foreign Business License from Thailand’s Ministry of Commerce, enabling local operations. Details on expansion here.
Aavas Financiers Secures Perpetual IRDAI License to Solicit Insurance Products
Aavas Financiers (AAVAS) receives IRDAI Certificate of Registration to act as a Corporate Agent, effective Dec 8, 2026, enabling insurance solicitation for customers.
Charms Industries Announces Change in Control; Patel Family to Acquire 24.37% Stake
Charms Industries announces a change in control as new promoters acquire 24.37% stake, triggering an open offer and a ₹30 crore fund raise via preferential issue.
Sudarshan Pharma Set for NSE Main Board Listing Following BSE SME Platform Migration
Sudarshan Pharma Industries migrates from BSE SME to NSE Main Board on October 27, 2026. Company reports 35.5% YoY profit growth and ₹752.06 Cr market cap.
Jaykay Enterprises Subsidiary Secures Lifetime CDSCO Licence for Advanced Medical Implants
Jaykay Enterprises subsidiary JK Digital receives a lifetime CDSCO licence to manufacture 8 categories of Class C/D orthopaedic and spinal implants in India.
Zydus Lifesciences Secures USFDA Approval for Menopause Patch with 180-Day Exclusivity
Zydus Lifesciences receives USFDA approval for Estradiol and Levonorgestrel Transdermal System, targeting a USD 45.7 million US market with 180-day exclusivity.
Dr. Reddy's Shares Jump 10% in 10 Days Since Zytorvi DCGI Approval for Esophageal Cancer
Dr. Reddy's Laboratories receives DCGI approval for Zytorvi for advanced esophageal cancer treatment in India. The drug reduced death risk by 42% in trials.
Nuvama Wealth Management Shares Surge 15% in 12 Days Since SEBI Approval for Investment Fund
Nuvama Asset Management receives SEBI approval for a Specialized Investment Fund. This follows a 22.6% YoY revenue jump to ₹1,376 Cr in the latest quarter.
